New Edge Advisors, LLC Astrazeneca PLC Transaction History

New Edge Advisors, LLC

$18.3 Billion
Q2 2025

A detailed history of New Edge Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, New Edge Advisors, LLC holds 73,646 shares of AZN stock, worth $5.71 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

73,646

Previous 73,882 0.32%

Holding current value

$5.71 Million

Previous $5.43 Million 5.23%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	SELL	$64.87 - $75.0 $15,309 - $17,700	-236 Reduced 0.32%	73,646 $5.15 Million
Q1 2025 May 15, 2025	BUY	$65.37 - $77.96 $92,433 - $110,235	1,414 Added 1.95%	73,882 $5.43 Million
Q4 2024 Feb 13, 2025	BUY	$63.2 - $79.58 $1.12 Million - $1.41 Million	17,721 Added 32.37%	72,468 $4.75 Million
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $395,463 - $451,943	5,158 Added 10.4%	54,747 $4.27 Million
Q2 2024 Aug 15, 2024	BUY	$66.81 - $80.83 $386,094 - $467,116	5,779 Added 13.19%	49,589 $3.87 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $363,677 - $414,567	5,959 Added 15.74%	43,810 $2.97 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $211,973 - $237,284	3,425 Added 9.95%	37,851 $2.55 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $194,679 - $215,243	3,002 Added 9.55%	34,426 $2.33 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $81,794 - $88,697	-1,170 Reduced 3.59%	31,424 $2.25 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $59,550 - $67,518	-943 Reduced 2.81%	32,594 $2.26 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $100,667 - $130,807	1,857 Added 5.86%	33,537 $2.27 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $848 - $2,172	16 Added 0.05%	31,680 $1.74 Million
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $974,352 - $1.17 Million	-16,442 Reduced 34.18%	31,664 $2.09 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $146,320 - $176,257	2,626 Added 5.77%	48,106 $3.19 Million
Q4 2021 Feb 17, 2022	BUY	$54.02 - $63.83 $61,042 - $72,127	1,130 Added 2.55%	45,480 $2.65 Million
Q3 2021 Oct 29, 2021	SELL	$55.56 - $60.79 $644,162 - $704,799	-11,594 Reduced 20.72%	44,350 $2.66 Million
Q2 2021 Jul 22, 2021	SELL	$48.42 - $60.18 $146,857 - $182,525	-3,033 Reduced 5.14%	55,944 $3.35 Million
Q1 2021 Apr 26, 2021	SELL	$47.16 - $54.44 $12.5 Million - $14.4 Million	-264,096 Reduced 81.74%	58,977 $2.93 Million
Q4 2020 Jan 27, 2021	BUY	$48.52 - $58.02 $15 Million - $17.9 Million	308,954 Added 2188.21%	323,073 $16.2 Million
Q3 2020 Nov 03, 2020	BUY	$53.07 - $61.1 $749,295 - $862,670	14,119 New	14,119 $774,000
Q1 2020 May 04, 2020	SELL	$37.79 - $51.33 $185,662 - $252,184	-4,913 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$42.46 - $50.46 $15,497 - $18,417	-365 Reduced 6.92%	4,913 $245,000
Q3 2019 Nov 06, 2019	BUY	$40.12 - $45.47 $211,753 - $239,990	5,278 New	5,278 $233,000
Q3 2017 Nov 13, 2017	SELL	$28.96 - $34.0 $21,053 - $24,718	-727 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	727	727 $0

Others Institutions Holding AZN

# of Institutions

1,415

Shares Held

497M

Call Options Held

7.11M

Put Options Held

2.56M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $240B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account

New Edge Advisors, LLC Astrazeneca PLC Transaction History